FDA Approves Expanded Indication for Dovato to Include Adolescent Patients with HIV

Dovato is the first oral, two-drug, single-tablet regimen approved for patients 12 years of age and older who are living with HIV-1.

Source link
#FDA #Approves #Expanded #Indication #Dovato #Include #Adolescent #Patients #HIV